Search

everythinglearnresearchcommunity

for

Search:↓

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Higher doses of prednisone and triamcinolone acetonide successfully treated 8 out of 10 alopecia totalis patients.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Retinoic acid and DMSO improve gene delivery to mouse skin for potential hair and skin disease treatment.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Ulcerative sarcoidosis in body folds is rare and improved with prednisone and hydroxychloroquine.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

High-dose iron therapy improves anemia without affecting IBD treatment.

MSC exosome therapy improved hair quality in patients with acquired trichorrhexis nodosa.

Baricitinib can cause excessive hair growth.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Liposomal delivery systems improve drug absorption through the skin, offering potential for better treatments.

Tofacitinib is an effective and safe treatment for alopecia areata.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Two specific SNPs in the TRPS1 gene cause excessive hair growth by altering the protein's structure.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.